Masimo Corporation (MASI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Masimo Corporation (MASI:NASDAQ), powered by AI.

Current Price
$179.95
P/E Ratio
-63.7
Market Cap
9.6B
Sector
Healthcare
What is the Masimo Corporation stock price forecast?

Masimo Corporation is currently trading at $179.95. View real-time AI analysis on Alpha Lenz.

What is Masimo Corporation insider trading activity?

View the latest insider trading data for Masimo Corporation on Alpha Lenz.

What is Masimo Corporation's P/E ratio?

Masimo Corporation's P/E ratio is -63.7.

Masimo Corporation

NASDAQ · MASI
$179.95+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Masimo Corporation's future dividend policy...
Alpha Chat Insight

Masimo Corporation trades at a P/E of -63.7 (undervalued) with modest ROE of -17.1%. Operating margin of 20.5% indicates strong profitability.

Ask for details

Company Overview

Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.

CEOMs. Catherine M. Szyman
SectorHealthcare
IndustryMedical Devices
Employees3,600

Company Statistics

FY 2025

Profile

$9.65BMarket Cap
$1.53BRevenue
0.00Shares Out
3,600Employees

Margins

61.90%Gross
23.25%EBITDA
20.49%Operating
17.85%Pre-Tax
-9.92%Net

Valuation

-63.67P/E
13.37P/B
6.32EV/Sales
28.32EV/EBITDA
49.95P/FCF

Growth (CAGR)

-9.14%Rev 3Yr
5.95%Rev 5Yr
14.20%Op Inc 3Yr
4.15%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.01%ROA
-17.09%ROE
14.14%ROIC

Financial Health

$152.30MCash & Cash Equivalents
$825.40MNet Debt
135.57%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Masimo Corporation (ticker: MASI) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 3,600 employees. Market cap is $9.6B.

The current price is $179.95 with a P/E ratio of -63.67x and P/B of 13.37x.

ROE is -17.09% and operating margin is 20.49%. Annual revenue is $1.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Masimo Corporation (MASI) Stock Forecast 2026 $179.95 — Price, Financials & Analyst Targets | Alpha Lenz